You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 16, 2025

Patent: 10,610,601

✉ Email this page to a colleague

Summary for Patent: 10,610,601

Title:	Polymeric antibiotics
Abstract:	The disclosure provides, inter alia, polymeric antibiotic compounds such as modified chitosans and methods of use thereof.
Inventor(s):	Young Jik Kwon, Julius Edson
Assignee:	University of California San Diego UCSD
Application Number:	US15/847,492
Patent Claims:	see list of patent claims

Details for Patent 10,610,601

Glossary

Subscribe to access the full database, or Get Started Free
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Novo Nordisk Inc.	TRESIBA	insulin degludec	Injection	203314	September 25, 2015	10,610,601	2037-12-19
Novo Nordisk Inc.	TRESIBA	insulin degludec	Injection	203314	November 21, 2018	10,610,601	2037-12-19
Sanofi-aventis U.s. Llc	ADLYXIN	lixisenatide	Injection	208471	July 27, 2016	10,610,601	2037-12-19
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Approval Date	>Patent No.	>Expiredate

International Patent Family for US Patent 10,610,601

Subscribe to access the full database, or Get Started Free
Country	Patent Number	Estimated Expiration
United States of America	9889204	⤷ Get Started Free
United States of America	2018110866	⤷ Get Started Free
United States of America	2016038601	⤷ Get Started Free
>Country	>Patent Number	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.